Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by Mbxwatcheron Dec 27, 2022 11:30am
173 Views
Post# 35192436

RE:Extra lump of coal in our stocking this year

RE:Extra lump of coal in our stocking this yearRaze, you and Wizz are the two posters that help keep me relatively sane on this.
Ultimately my real issue here has been one of managing expectations.......my expectations.

These expectations have been driven to an extent by the enthusiasm of the presentations done by Microbix over the past few years.   As this is one of only two microcaps I own, I continued to buy the "hype"  When i use that term I do not wish to imply that the hype was artificial.  I entirely believe that thought VTM was originally an explosive addition to their products, that a Kinlytic deal was imminent, and that they would be signing POC agreements at a much higher and faster rate than they were.

Ultimately, I am certain that they as dissapointed with Q4 as we are, especially given the 'suggestions' that it would be transformational....I suspect that held our feet firmly on the ground throughout 2022 when the share price slid with the market.  I for one, was waiting and anticipating a big 4th quarter, and was quite dissapointed with the last presentation which made it clear immediate good news was not forthcoming.

Finally, I think all that is left for me is to recalibrate my timing and my investment expectations.  I had hoped to 'lighten the load at the end of 2022, and instead will recalibrate to buying some omore on current weakness in early 2023".    Wizz keeps saying the long term outlook hasnt changed only the timing has.  Ive been in since 2009, so for me timing is not inconsequential.....but thats Small cap investing I guess.
<< Previous
Bullboard Posts
Next >>